Financial Year |
March 31 2023 |
Monetary Funds |
1,161,576,791.82 |
Held-for-trading Financial Assets |
110,000,000.00 |
Notes Receivable |
-- |
Accounts Receivable |
74,001,376.17 |
Advances to Suppliers |
21,601,813.02 |
Other Receivables |
9,022,309.70 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
94,997,615.70 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,022,089.94 |
Total Current Assets |
1,488,596,492.54 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
536,658,561.87 |
Under-construction Projects |
106,858,801.57 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
41,680,679.34 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
8,724,277.86 |
Other Non-Current Assets |
5,299,027.60 |
Sub-Total of Non-Current Assets |
709,484,348.24 |
Total Assets |
2,198,080,840.78 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
83,869,311.95 |
Accounts Payable |
101,508,242.13 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
20,349,489.81 |
Taxes Payable |
7,570,765.45 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
63,094,193.51 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
13,090,124.08 |
Sub-Total of Current Liabilities |
405,461,477.22 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
621,104.66 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
11,339,981.84 |
Total Liabilities |
416,801,459.06 |
Paid-In Capital(Or Share Stock) |
224,120,000.00 |
Capital Surplus |
899,935,142.87 |
Surplus Reserve |
65,541,653.27 |
LESS:Treasury Stock |
760,000.00 |
Undistributed Profits |
592,442,585.58 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,781,279,381.72 |
Owner's Equity(Stockholder's Equity) |
1,781,279,381.72 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,198,080,840.78 |